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Abstract
Introduction: The aim of the study was evaluation of the results of surgical treatment in patients with hyperparathyroidism related to 
MEN syndrome.
Material and methods: Five patients with MEN-related hyperparathyroidism were operated between January 1, 2010 and December 31, 
2016 — three women (60%) and two men (40%) aged between 17 and 72 years (mean 41.6 years). MEN1 syndrome was diagnosed in four 
patients and MEN2 only once. Pre- and postoperative results of PTH levels and serum calcium values were compared.
Results: The mean preoperative serum PTH level was 215.56 pg/ml (from 113.4 to 376.6 pg/ml), whereas the mean preoperative serum 
calcium concentration was 1.40 mmol/l (from 1.15 to 1.50 mmol/l). Patients with MEN1 syndrome had three and two thirds of parathy-
roid gland taken in these three cases, including two cases with a partial thyroid removal, and the last one had a parathyroid biopsy 
performed. A patient with MEN2 syndrome had one parathyroid gland excised and Dunhill surgery of the thyroid gland performed. 
A diagnosis of the parathyroid adenoma accompanying medullary thyroid cancer required additional resections for the diseased thyroid 
parenchyma and the neck dissection. Postoperatively, we reported decreased secretion of both PTHs, ranging from 2.0 to 18.4 pg/ml 
(a mean serum PTH concentration 6.72 pg/ml), and serum calcium concentration between 0.9 and 1.25 mmol/l (a mean serum calcium 
concentration 1.11 mmol/l). One patient (25%) with MEN 1 developed recurrent hyperparathyroidism five years after the surgery. The 
patient was reoperated. The rest of the parathyroid gland was removed with an implantation into separated muscle pockets in the 
anterior forearm muscles.
Conclusions: 
1. MEN syndrome is a rare cause of primary hyperparathyroidism.
2. Subtotal parathyroidectomy helps to restore normal calcium metabolism.
3. Recurrence of hyperparathyroidism in patients with MEN syndrome requires total parathyroidectomy with an autotransplantation 
into the anterior forearm muscles. (Endokrynol Pol 2018; 69 (2): 163–167)
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Streszczenie
Wstęp: Celem pracy była ocena wyników leczenia chirurgicznego pacjentów z nadczynnością przytarczyc w przebiegu zespołu MEN.
Materiał i metodyka: Zespół MEN stwierdzono u 3 kobiet i 2 mężczyzn w wieku 17–72 lata (średnio 41,6) spośród 419 chorych operowa-
nych w latach 2010–2016 z powodu pierwotnej nadczynności przytarczyc. Zespół MEN1 zdiagnozowano u 4 chorych zaś MEN2 jednej. 
W pracy porównano stężenia parathormonu (PTH) i wapnia zjonizowanego (Ca2+) w surowicy krwi przed i po operacji. 
Wyniki: U chorych z zespołem MEN średnie przedoperacyjne stężenie PTH wyniosło 215,56 pg/ml a Ca2+ 1,4 mmol/l. W przebiegu MEN1 
u trzech chorych wycięto 3 i 2/3 przytarczyc, u jednego zaś jedną przytarczycę z biopsją pozostałych. U chorej z MEN2 wycięto jedną 
przytarczycę z całkowitym wycięciem tarczycy i węzłów chłonnych szyi. Pooperacyjnie odnotowano spadek stężeń PTH do wartości 
średnio 6,72 pg/ml oraz Ca2+ do 1,11 mmol/l w surowicy krwi. U jednego chorego z zespołem MEN1 doszło do nawrotu nadczynności 
przytarczyc po 5 latach od operacji. Chory ponownie operowany — wycięcie pozostałej przytarczycy z autotransplantacją fragmentu 
do mięśni przedramienia. 
Wnioski: 
1. Zespół MEN jest rzadką przyczyną nadczynności przytarczyc
2. Częściowa subtotalna resekcja przytarczyc przywraca prawidłowy metabolizm wapnia.
3. Nawrót nadczynności przytarczyc u pacjentów z zespołem MEN wymaga całkowitej resekcji przytarczyc z autotransplantacją fragmentu 
do mięśni przedramienia. (Endokrynol Pol 2018; 69 (2): 163–167)
Słowa kluczowe: mnoga gruczolakowatość wewnątrzwydzielnicza, nadczynność przytarczyc, rak tarczycy, paratyreoidektomia
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Introduction
Primary hyperparathyroidism (PHPT) is most fre-
quently found (95% of patients) in sporadic form [1, 
2], whereas it appears rarely (5% of patients) in familial 
form as a syndrome of multiple endocrine neoplasia 
(MEN). The appearance of MEN is connected with MEN 
1 gene mutation and leads to Wermer syndrome or that 
of RET gene in MEN 2A syndrome [3].
Surgical treatment is the most effective method of 
dealing with PHPT, and its extent depends on the type 
of pathology within parathyroid glands [4–6].
The aim of the study
The aim of the study was to evaluate the follow-up 
studies of the surgical treatment of patients with PHPT 
related to multiple endocrine neoplasia.
Material and methods
A total of 419 patients were operated on for various 
types of hyperparathyroidism between January 1, 
2010 and December 31, 2016. Five of them (1.2%) 
were diagnosed with a multiple endocrine neoplasia 
syndrome confirmed by genetic tests. The latter group 
consisted of three women (60%) and two men (40%) 
aged 17–72 years, with a mean age 41.6 years. MEN 1 
syndrome was diagnosed in four patients, and MEN2 
in one. Localisation of the lesions was stated on MIBI-
SPECT scintigraphy with preoperative USG. Moreover, 
PTH, ionised calcium, creatinine level, and glomerular 
filtration rate (GFR) were measured. All patients were 
operated under general anaesthesia by classic method. 
Bilateral neck exploration was done, and all parathy-
roid glands were identified. Preoperative results were 
compared with those obtained postoperatively.
Results
Tumours of other endocrine organs in MEN1 disease 
were identified in group of four patients with primary 
hyperparathyroidism (Tab. I). Concomitance of pitui-
tary tumour was seen in three patients — twice soma-
totropinoma and once prolactinoma. Two patients were 
treated for pancreatic tumour — one insulinoma and 
one gastrinoma. Concomitance of adrenal tumour was 
noticed in one patient. Preoperative serum PTH value 
was 113.4–218.0 pg/ml (mean 188.35 pg/ml) in MEN1 
patients, whereas Ca2+ was 1.15–1.45 mmol/l (mean 
1.29 mmol/l). Before operation all patients were treated 
with cinacalcet. Three of them underwent total resec-
tion of three affected glands with partial resection of the 
fourth and subtotal resection of the thyroid gland, and 
bilateral neck exploration in two cases. The one patient 
underwent total resection of one parathyroid gland. 
Surgical biopsy of the remaining glands was done. 
Histopathological examinations revealed hyperplasia of 
all resected parathyroid glands. On the first postopera-
tive day PTH level decreased to 2.0–18.4 pg/ml (mean 
8.2 pg/ml), whereas Ca2+ decreased to 1.10–1.25 mmol/l 
(mean 1.14 mmol/l). Recurrent hyperparathyroidism 
developed after five years in one patient (33.3%). PTH 
grew up to 84.89 pg/ml and total Ca to 2.57 mmol/l. He 
was reoperated, and the gland was resected. Part of it 
was implanted into the patient’s forearm muscle and 
the rest was covered for later use. A rapid PTH value 
drop was noticed to 2.34 pg/ml and Ca2+ to 1.06 mmol/l.
MEN2A syndrome was diagnosed in one patient 
operated for primary hyperparathyroidism after 
surgical treatment and histopathological verification. 
The MEN2 female patient revealed preoperative se-
rum PTH value 376.6 pg/ml, whereas ionised calcium 
was 1.27 mmol/l. She underwent total resection of 
the parathyroid adenoma and Dunhill operation. 
Histopathological examination revealed a parathyroid 
adenoma with concomitant thyroid medullary cancer. 
Finally, resection of the remaining thyroid stump 
was decided together with resection of the middle 
compartment and lateral compartments of the neck. 
Genetic examination revealed familial papillary thy-
roid carcinoma with RET proto-oncogene mutation. 
Table I. Patients operated due to MEN syndrome — characteristic of polyglandular pathology
Tabela I. Operowani pacjenci z zespołem MEN — charakterystyka niedoczynności wielogruczołowej
No Sex Age
Endocrine gland pathology
Parathyroid Thyroid Pituitary Pancreas Adrenal gland Ovaries
1 M 26 PHPT — hyperplasia 3 Nodular goitre Prolactinoma Gastrinoma
2 F 17 PHPT — hyperplasia 1 Nodular goitre Somatotropinoma PCOD
3 F 72 PHPT — hyperplasia 3 Nodular goitre Somatotropinoma Insulinoma Non-functional 
adenoma
4 M 33 PHPT — hyperplasia 3 Nodular goitre
5 F 60 PHPT — adenoma Medullar carcinoma (RET+) Bilateral adenoma 
non-functional
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A drop of PTH was noted (to 2.5 pg/ml) and Ca2+ (to 
0.9 mmol/l). After four years she is alive with no symp-
toms of the disease or cancer. Calcitonin 18.7 pg/ml 
(N < 11.5) and carcino embryonic antigen CEA 
1.54 ng/ml (N < 5) levels are both postoperatively 
stagnant. (not suspicious for carcinoma tumour — 
no data before operation). Imaging explorations (CT 
scan and ultrasound) did not reveal a relapse of the 
regional thyroid carcinoma. Abdominal CT scan con-
firmed non-functional adrenal adenomas. 
Discussion
Clinical symptoms of PHPT are often the first fully 
recognised signs of endocrinopathy that can be found 
in multiple endocrine neoplasia [7]. The responsible 
factor is often hyperplasia of the glands, which we 
observed not only in all patients operated with MEN 1 
in our hospital, but also with adenoma, as in the case 
of the patient with MEN 2A [1, 3, 8]. Another cause of 
the hyperparathyroidism can be connected with para-
thyroid cancer [3, 9, 10].
Nowadays the surgical treatment of PHPT is the 
treatment of choice. However, results of such treatment 
are often too difficult to predict, for many reasons, both 
diagnostic and therapeutic, that a surgeon must face. 
The main goal of such an operation is to guarantee nor-
mocalcaemia and minimal risk of recurrence [7]. In the 
treatment of a recurrence, precise and easy identifica-
tion of the affected gland is necessary [6]. On the other 
hand, the surgeon should protect the patient against 
persistent and permanent calcium deficiency, which is 
often very troublesome for the patient [11].
Very crucial is the surgeon’s experience [11, 12]. 
Before surgery precise imaging diagnostics should be 
performed to consider the number and location of the 
affected parathyroid glands. Preoperative USG of the 
neck and SPECT MIBI-TC scintigraphy of parathyroid 
glands usually help to localise the affected glands [13, 14]. 
Concomitant lesions within the thyroid gland may 
also play a role when making a choice of the operative 
method [13]. The presence of focal lesions or changes 
in the thyroid gland may require a fine-needle biopsy, 
in addition. In such a situation, we are convinced 
that fine-needle biopsy should be guided when the 
parathyroid gland is revealed. We fear that parathyroid 
cells might be disseminated. If a malignant lesion is 
suspected a total resection of the thyroid gland with 
a cervical lymphadenectomy is performed [8, 15, 16]. 
This is confirmed by our observations. All three MEN1 
patients required additional partial resection of the 
thyroid gland, but one MEN 2A female required radical 
resection of the thyroid gland accompanied by resection 
of cervical lymph nodes.
Minimally invasive techniques have become more 
and more popular recently [17, 18]. There are still 
discussions among surgeons on the choice of either 
conventional techniques with bilateral identification of 
the parathyroid gland or minimally invasive methods. 
Hypertrophy of the parathyroid glands (as we observed 
in all MEN 1 patients in our study), the presence of 
multiple adenomatous lesions leading to PHPT, or the 
absence of preoperative clear location of the affected 
glands required a conventional technique, which was 
a method of choice [11].
On the other hand, preoperative identification of 
the affected parathyroid glands may require minimally 
invasive techniques. However, it is important to remem-
ber that hyperplastic lesions, diagnosed by scintigraphy, 
usually refer only to the dominant gland [14]. There-
fore the efficacy of the operative treatment should be 
verified by intraoperative blood serum parathormone 
Figure 1. Pre- and postoperative PTH levels in blood serum in 
patients treated for MEN1
Rycina 1. Stężenie PTH w surowicy krwi przed i pooperacyjne 
u chorych operowanych z powodu MEN1
Figure 2. Pre- and postoperative Ca2+ levels in serum in patients 
treated for MEN1
Rycina 2. Przed- i pooperacyjne stężenie Ca2+ w surowicy krwi 
u chorych operowanych z powodu MEN1
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concentration [7, 19]. This may impose a decision to 
finish the operation or to continue exploration of the 
neck in order to search for the cause of the disease. 
It is essential to determine whether the symptoms of 
hyperparathyroidism persist or recur because each 
subsequent surgical intervention will increase the risk 
of complications developing, particularly in recurrent 
laryngeal nerves. Therefore, we recommended specifi-
cally the use of neuromonitoring.
The extent of surgical HPT treatment in MEN syn-
dromes has not been determined yet, although it has an 
influence on the treatment efficacy. Some surgeons pre-
fer a subtotal parathyroidectomy and others recommend 
a total resection of parathyroid glands accompanied by 
autotransplantation on forearm muscles [5, 7, 15, 20]. 
Each of the techniques is part of the operation for recur-
rent hyperparathyroidism [4, 21], probably caused by 
supernumerary glands in ectopic position and oversized 
stump of the partially resected gland. Some surgeons 
decide to perform thymus resection, in addition [6, 22]. 
Another cause of recurrent hyperparathyroidism may 
also be connected with an autologous transplant on the 
forearm. Surgeons who prefer total parathyroidectomy 
followed by autotransplantation on forearm muscles 
indicate that it is easy to remove afterwards, when 
HP recurrence is diagnosed. They also point out that 
it may be technically easy to identify the transformed 
parathyroid gland, and the number of postoperative 
complications, such as recurrent laryngeal nerve palsy, 
lymphorrhagia, or Horner’s syndrome, might be lim-
ited. During the process of subtotal parathyroidectomy, 
it is very useful to place a marker in the region of the 
left gland in the form of a non-absorbable suture of 
titanic clip in order to identify the parathyroid recur-
rence [6]. It is also very important to become familiar 
with all the data related to the previous surgeries as well 
as the diagnostic imaging test results. There are some 
surgeons who state that minimally invasive techniques 
are adequate to remove the gland with the macroscopic 
change while the risk of a recurrence is small and usu-
ally distant in time [17, 18]. Another theory emphasises 
that subtotal parathyroidectomy is more comfortable 
than the total resection of all the glands accompanied 
by autotransplantation of the parathyroid homogenate 
to the forearm muscle, even though such a procedure 
requires securing of the material for further use by 
a high percentage of uncomfortable hypocalcaemia [23]. 
Nevertheless, it requires additional highly specialised 
laboratory techniques. The operative treatment of 
parathyroid glands as a component of MEN should be 
managed by highly specialised centres that are provided 
with experienced surgical staff.
Figure 3. Intraoperative view of parathyroid gland in MEN 1 syndrome. A. Enlarged parathyroid gland prepared for partial resection; 
B. State after partial parathyroid resection — inserted titanium clip; C. 3 and 3/4 parathyroid glands with hyperplasia — post resection view
Rycina 3. Obraz śródoperacyjny przytarczyc w zespole MEN 1. A. Zmieniona rozrostowo przytarczyca wypreparowana do częściowej 
resekcji; B. Stan po resekcji częściowej przytarczycy — założony klips tytanowy; C. Zresekowane 3 i ¾ przytarczyce zmienione rozrostowo
A
B C
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Conclusions
1. MEN is a rare cause of primary hyperparathy-
roidism.
2. Subtotal parathyroidectomy helps to restore normal 
calcium metabolism.
3. HPT recurrence in MEN patients requires total 
parathyroidectomy probably followed by autotrans-
plantation to forearm muscles.
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